Clinical Trials Directory

Trials / Unknown

UnknownNCT01926600

Sublingual Administration of PPI

Sublingual Administration is More Fast Than Oral or IV Administration in PPI Dosing With Respect to Intragastric pH and Therapeutic Effectiveness: a Prospective, Randomized, Controlled Trial

Status
Unknown
Phase
Study type
Observational
Enrollment
60 (estimated)
Sponsor
The Catholic University of Korea · Academic / Other
Sex
All
Age
20 Years – 75 Years
Healthy volunteers
Not accepted

Summary

Compare 24-hour intragastric pH and therapeutic effectiveness of proton pump inhibitor (PPI) among different administration methods: per oral (PO), intravenous (IV), and sublingual (SL).

Detailed description

Intragastric pH and therapeutic effectiveness of PPI was compared among patients given PPI with different administration methods. 24 hour intragastric pH catheter was inserted in stomach of patients with peptic ulcer an hour prior to PPI administration in order to observe the initial change in pH. Three groups of patients were given PPI through per oral, intravenous, and sublingual administration methods. The hypothesis of this study is that sublingual administration will be faster than oral or IV administration in PPI dosing with respect to intragastric pH change and re-bleeding rate.

Conditions

Timeline

Start date
2013-08-01
Primary completion
2013-11-01
Completion
2013-12-01
First posted
2013-08-21
Last updated
2013-08-21

Locations

1 site across 1 country: South Korea

Source: ClinicalTrials.gov record NCT01926600. Inclusion in this directory is not an endorsement.

Sublingual Administration of PPI (NCT01926600) · Clinical Trials Directory